ZIMV
Company Description
ZimVie Inc. operates as a medical technology enterprise, specializing in the design, manufacturing, and global distribution of an extensive array of products and solutions. These offerings are engineered to address various spinal conditions and facilitate dental tooth replacement and restorative procedures. Its comprehensive dental portfolio encompasses implant systems, along with associated prosthetic and abutment components, and the necessary surgical instrumentation and kits. The company also supplies advanced regenerative products such as bone grafts, barrier membranes, allografts, and collagen-based wound care solutions. Furthermore, it provides cutting-edge digital dentistry tools, including intraoral scanners, virtual treatment planning services, guided surgery capabilities, CAD/CAM workflow systems, and customized restorative parts. In the spinal segment, ZimVie offers a range of fusion implants and specialized instrumentation for diverse surgical interventions, including biologics and innovative bone healing technologies. Notably, its specialized spinal offerings include minimally invasive surgery (MIS) solutions, exemplified by products like Vital MIS and Timberline, as well as advanced motion preservation technologies such as Mobi-C and The Tether. Established in 2021, ZimVie Inc. maintains its corporate headquarters in Westminster, Colorado.
Track Record
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 449.75M | 457.43M | 913.86M | 1.01B | 912.40M | 1.06B | 1.10B |
| Net Income | (25.82M) | (393.28M) | (63.88M) | (95.30M) | (179.00M) | (27.90M) | (460.40M) |
| EPS | -0.94 | -14.87 | -2.45 | -3.65 | -6.86 | -1.07 | -17.64 |
| Free Cash Flow | 7.49M | 24.66M | (1.92M) | 7.70M | 47.70M | 66.20M | 113.70M |
| FCF / Share | 0.27 | 0.93 | -0.07 | 0.30 | 1.83 | 2.54 | 4.36 |
| Operating CF | 14.17M | 37.15M | 24.63M | 64.30M | 86.00M | 119.20M | 162.00M |
| Total Assets | 753.67M | 1.21B | 1.64B | 1.83B | 1.95B | 2.11B | N/A |
| Total Debt | 232.57M | 521.93M | 564.14M | 57.90M | 89.20M | 86.00M | N/A |
| Cash & Equiv | 74.97M | 71.51M | 89.60M | 100.40M | 27.40M | 37.00M | N/A |
| Book Value | 381.71M | 409.49M | 758.60M | 1.45B | 1.49B | 1.67B | N/A |
| Return on Equity | -0.07 | -0.96 | -0.08 | -0.07 | -0.12 | -0.02 | N/A |
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116.66M | 112.00M | 111.52M | 103.22M | 116.81M | 118.19M | 113.07M | 202.87M | 224.90M | 225.43M | 229.12M | 214.58M |
| Net Income | (3.95M) | (1.47M) | (11.77M) | (2.28M) | (4.01M) | (7.76M) | (334.85M) | (5.09M) | (23.37M) | (29.97M) | (30.34M) | 831,000 |
| EPS | -0.14 | -0.05 | -0.43 | -0.08 | -0.15 | -0.29 | -12.37 | -0.19 | -0.89 | -1.14 | -1.16 | 0.03 |
| Free Cash Flow | 1.65M | (15.41M) | 18.76M | 615,000 | 1.78M | (13.66M) | 18.65M | 18.06M | (1.01M) | (11.03M) | (14.29M) | (6.05M) |
| FCF / Share | 0.06 | -0.56 | 0.68 | 0.02 | 0.06 | -0.50 | 0.69 | 0.68 | -0.04 | -0.42 | -0.55 | -0.23 |
| Operating CF | 3.23M | (13.91M) | 21.45M | 1.20M | 3.04M | (11.51M) | 21.45M | 22.63M | 256,000 | (7.20M) | (8.90M) | 2.85M |
| Total Assets | 758.22M | 745.78M | 753.67M | 782.95M | 789.79M | 1.17B | 1.21B | 1.51B | 1.56B | 1.59B | 1.64B | 1.63B |
| Total Debt | 234.54M | 232.71M | 232.57M | 234.20M | 249.20M | 522.56M | 521.93M | 543.02M | 549.53M | 552.27M | 564.14M | 582.67M |
| Cash & Equiv | 70.18M | 66.75M | 74.97M | 66.81M | 78.60M | 43.53M | 71.51M | 75.45M | 66.21M | 66.41M | 89.60M | 116.01M |
| Book Value | 412.80M | 395.12M | 381.71M | 406.64M | 394.10M | 388.33M | 409.49M | 710.20M | 727.84M | 743.60M | 758.60M | 733.78M |
| Return on Equity | -0.01 | -0.00 | -0.03 | -0.01 | -0.01 | -0.02 | -0.82 | -0.01 | -0.03 | -0.04 | -0.04 | 0.00 |